Literature DB >> 3707089

Effect of dexamethasone on blood-brain barrier in the normal mouse.

E T Hedley-Whyte, D W Hsu.   

Abstract

Dexamethasone ameliorates cerebral edema, but its effect on normal blood-brain barrier is unknown, as is the site of action. Sixteen normal mice were given dexamethasone, 3 mg/kg intramuscularly or 2 mg/kg intravenously. One to two hours later 10 mg of horseradish peroxidase (HRP) in 0.1 ml of saline was administered intravenously and allowed to circulate for 15 minutes. Brain slices were examined by light and electron microscopy. The number of HRP-permeable arteriolar segments per brain was less in dexamethasone-treated than in control mice (p less than 0.001). In addition, the number of small HRP-filled endothelial vesicles of capillaries and of HRP-permeable and -impermeable arterial segments was less in dexamethasone-treated mice than that for similar vessels in control mice (p less than 0.005, p less than 0.05, and p less than 0.01, respectively). The total number of small vesicles and the number of larger HRP-filled vesicles in arterioles was the same in treated and control mice. Dexamethasone therefore decreased the normal permeability of cerebral blood vessels to HRP. This decrease was accompanied by a decrease in the number of HRP-containing small endothelial vesicles. These data suggest that dexamethasone influences cerebral edema by decreasing the permeability of the cerebral vasculature for macromolecules.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3707089     DOI: 10.1002/ana.410190411

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  14 in total

1.  Discrepant longitudinal volumetric and metabolic evolution of diffuse intrinsic Pontine gliomas during treatment: implications for current response assessment strategies.

Authors:  U Löbel; S Hwang; A Edwards; Y Li; X Li; A Broniscer; Z Patay
Journal:  Neuroradiology       Date:  2016-07-20       Impact factor: 2.804

2.  Central pontine myelinolysis: historical and mechanistic considerations.

Authors:  Michael D Norenberg
Journal:  Metab Brain Dis       Date:  2010-02-25       Impact factor: 3.584

Review 3.  Medical management of patients with brain tumors.

Authors:  Patrick Y Wen; David Schiff; Santosh Kesari; Jan Drappatz; Debra C Gigas; Lisa Doherty
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

4.  Focal radiation therapy of brain metastases after complete surgical resection.

Authors:  Gautam Bahl; Greg White; John Alksne; Lakshmi Vemuri; Matthew A Spear
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

5.  Stress does not increase blood-brain barrier permeability in mice.

Authors:  Martin Roszkowski; Johannes Bohacek
Journal:  J Cereb Blood Flow Metab       Date:  2016-05-04       Impact factor: 6.200

6.  The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.

Authors:  Anargyros Xenocostas; Wing K Cheung; Francis Farrell; Cindy Zakszewski; Marian Kelley; Andrzej Lutynski; Michael Crump; Jeffrey H Lipton; Thomas L Kiss; Catherine Y Lau; Hans A Messner
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

Review 7.  Corticosteroids in brain cancer patients: benefits and pitfalls.

Authors:  Jörg Dietrich; Krithika Rao; Sandra Pastorino; Santosh Kesari
Journal:  Expert Rev Clin Pharmacol       Date:  2011-03       Impact factor: 5.045

Review 8.  Neurovascular glucocorticoid receptors and glucocorticoids: implications in health, neurological disorders and drug therapy.

Authors:  Sherice Williams; Chaitali Ghosh
Journal:  Drug Discov Today       Date:  2019-09-18       Impact factor: 7.851

9.  Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema.

Authors:  Cameron J Herting; Zhihong Chen; Victor Maximov; Alyssa Duffy; Frank Szulzewsky; Dmitry M Shayakhmetov; Dolores Hambardzumyan
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501

10.  Chemokine expression in human astrocytes in response to shiga toxin 2.

Authors:  Naomi Kioka; Koichi Minami; Akira Tamura; Norishige Yoshikawa
Journal:  Int J Inflam       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.